Fidarsi o no del ColorChecker?

Il ColorChecker \ue8 uno strumento usato nel campo della fotografia digitale per eseguire una calibrazione cromatica. Il pannello composto da 24 tasselli a colori viene inserito all\u2019interno di una fotografia digitale per avere una acquisizione di valori di riferimento noti. L\u2019idea \ue8 quella che conoscendo i valori del ColorChecker e correggendo quelli relativi acquisiti si pu\uf2 calibrare cromaticamente tutta l\u2019immagine. L\u2019obiettivo di questo lavoro \ue8 testare i limiti e l\u2019affidabilit\ue0 dell\u2019uso del ColorChecker. A questo scopo sono state acquisite immagini fotografiche digitali a colori contenenti il ColorChecker a diverse condizioni di illuminazione e distanze dall\u2019obiettivo. Dopo aver corretto le immagini rispetto a un punto di bianco ottenuto dall\u2019apposito tassello del ColorChecker, \ue8 stata valutata la variabilit\ue0 dei tasselli colorati rispetto ai dati di fabbrica. Sono stati inoltre misurati il range dinamico relativo del ColorChecker e la linearit\ue0 dei valori di luminanza dei tasselli in scala di grigi rapportati ai valori corrispondenti dei dati di fabbrica

Durability of bioprosthetic aortic valves in patients under the age of 60 years - Rationale and design of the international INDURE registry

Background: There is an ever-growing number of patients requiring aortic valve replacement (AVR). Limited data is available on the long-term outcomes and structural integrity of bioprosthetic valves in younger patients undergoing surgical AVR. Methods: The INSPIRIS RESILIA Durability Registry (INDURE) is a prospective, open-label, multicentre, international registry with a follow-up of 5 years to assess clinical outcomes of patients younger than 60 years who undergo surgical AVR using the INSPIRIS RESILIA aortic valve. INDURE will be conducted across 20-22 sites in Europe and Canada and intends to enrol minimum of 400 patients. Patients will be included if they are scheduled to undergo AVR with or without concomitant root replacement and/or coronary bypass surgery. The primary objectives are to 1) determine VARC-2 defined time-related valve safety at one-year (depicted as freedom from events) and 2) determine freedom from stage 3 structural valve degeneration (SVD) presenting as morphological abnormalities and severe haemodynamic valve degeneration at 5 years. Secondary objectives include the assessment of the haemodynamic performance of the valve, all stages of SVD, potential valve-in-valve procedures, clinical outcomes (in terms of New York Heart Association [NYHA] function class and freedom from valve-related rehospitalisation) and change in patient quality-of-life. Discussion: INDURE is a prospective, multicentre registry in Europe and Canada, which will provide much needed data on the long-term performance of bioprosthetic valves in general and the INSPIRIS RESILIA valve in particular. The data may help to gather a deeper understanding of the longevity of bioprosthetic valves and may expand the use of bioprosthetic valves in patients under the age of 60 years. Trial registration: ClinicalTrials.gov identifier: NCT03666741 (registration received September, 12th, 2018)

A decade of living lobar lung transplantation: recipient outcomes

AbstractObjectiveLiving lobar lung transplantation was developed as a procedure for patients considered too ill to await cadaveric transplantation.MethodsOne hundred twenty-eight living lobar lung transplantations were performed in 123 patients between 1993 and 2003. Eighty-four patients were adults (age, 27 ± 7.7 years), and 39 were pediatric patients (age, 13.9 ± 2.9 years).ResultsThe primary indication for transplantation was cystic fibrosis (84%). At the time of transplantation, 67.5% of patients were hospitalized, and 17.9% were intubated. One-, 3-, and 5-year actuarial survival among living lobar recipients was 70%, 54%, and 45%, respectively. There was no difference in actuarial survival between adult and pediatric living lobar recipients (P = .65). There were 63 deaths among living lobar recipients, with infection being the predominant cause (53.4%), followed by obliterative bronchiolitis (12.7%) and primary graft dysfunction (7.9%). The overall incidence of acute rejection was 0.8 episodes per patient. Seventy-eight percent of rejection episodes were unilateral. Age, sex, indication, donor relationship, preoperative hospitalization status, use of preoperative steroids, and HLA-A, HLA-B, and HLA-DR typing did not influence survival. However, patients on ventilators preoperatively had significantly worse outcomes (odds ratio, 3.06, P = .03; Kaplan-Meier P = .002), and those undergoing retransplantation had an increased risk of death (odds ratio, 2.50).ConclusionThese results support the continued use of living lobar lung transplantation in patients deemed unable to await a cadaveric transplantation. We consider patients undergoing retransplantations and intubated patients to be at significantly high risk because of the poor outcomes in these populations

Durability of bioprosthetic aortic valves in patients under the age of 60 years - Rationale and design of the international INDURE registry

Background: There is an ever-growing number of patients requiring aortic valve replacement (AVR). Limited data is available on the long-term outcomes and structural integrity of bioprosthetic valves in younger patients undergoing surgical AVR. Methods: The INSPIRIS RESILIA Durability Registry (INDURE) is a prospective, open-label, multicentre, international registry with a follow-up of 5 years to assess clinical outcomes of patients younger than 60 years who undergo surgical AVR using the INS

More than two decades after the introduction of Limnoperna fortunei (Dunker 1857) in La Plata Basin

<div><p>Abstract The golden mussel, Limnoperna fortunei, is an Asian freshwater bivalve introduced in South America in the beginning of the 1990’s, probably through ballast water releases in La Plata River estuary. It dispersed north through Paraná, Uruguay and Paraguay Rivers. The study evaluated the macroscale (18° to 34° S; 45° to 60° W) distribution of L. fortunei (larval stages) in the main rivers and reservoirs of La Plata Basin. Samplings were performed through 68 µm vertical plankton net hauls. Limnological variables were simultaneously determined. Larvae abundance correlated significantly with oxygen (positively) in summer, with temperature (positively) in winter and with total phosphorus and total nitrogen (both negatively) in winter. We expected densities to decrease towards north (latitudinal gradient) and increase in lentic conditions (reservoirs). Despite maximum density was found near the introduction point (La Plata River) similar value was also observed 2,000 km north (Paraguay River). The first hypothesis was refuted. The second hypothesis was partially accepted. Abundances were consistently higher in summer. Higher trophic conditions and fast flow seem to inhibit population growth. Food resources (chlorophyll a) locally influenced temporal variation. Limnoperna fortunei is widely distributed in La Plata basin, reaching high larval densities superior to 10,000 ind. m-3, in all major sub-basins. The species exhibits a high intrinsic dispersal ability (free planktonic larvae), wide tolerance to environmental factors and dispersion is potentialized by natural dispersion processes (e.g. fauna displacement) and human facilitation (e.g. commercial navigation).</p></div

Primary cardiac leiomyosarcoma: seven-year survival with combined surgical and adjuvant therapy

Primary cardiac sarcomas constitute a rare entity that have been uniformly associated with poor long-term survival. A case of left atrial leiomyosarcoma involving the interatrial septum and the right atrial free wall and presenting with syncope and atrial fibrillation, is described. Two extensive surgical excisions followed by adjuvant radiation and chemotherapy improved survival with a good quality of life. This approach of combined surgical, medical and radiation therapy may offer better longterm outcome, since our patient is the longest survivor thus far reported

Heparin-coated circuits for high-risk patients: a multicenter, prospective, randomized trial

BACKGROUND: Heparin-coated circuits (HCCs) in low-risk cardiac patients who have coronary revascularization have a limited impact on postoperative outcome. In this prospective, randomized investigation, we studied high-risk patients who had cardiac operations with or without HCCs. METHODS: A total of 886 patients who had cardiac operations with cardiopulmonary bypass and at least one patient-related or procedure-related risk factor were enrolled in a multicenter study. They were randomly allocated to have cardiopulmonary bypass with Duraflo II HCCs (HCC group, n = 442) or conventional circuits (control group, n = 444). Postoperative outcome was investigated with respect to the occurrence of organ dysfunction. RESULTS: HCCs are associated with a shorter intensive care unit and postoperative hospital stay and with a lower rate of patients having a severely impaired clinical outcome (stay in intensive care unit for more than 5 days or death) (relative risk 0.66, p = 0.045). Lung dysfunction rate was significantly lower for the patients in HCC group affected by chronic obstructive pulmonary disease or who had mitral procedure (relative risk, respectively, 0.31, p = 0.018 and 0.05, p = 0.02). Renal dysfunction rate was significantly (p = 0.05) lower for diabetics in the HCC group (relative risk 0.28). CONCLUSIONS: When HCCs were used postoperative times decreased and they had a protective effect on lung and kidney function in high-risk patients